Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor

News   Nov 27, 2017

 
Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor
 
 
 

RELATED ARTICLES

Agent Reverses Resistance to Targeted Drug in Some Leukemias

News

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.

READ MORE

Blueprints for Anti-cancer Drugs Identified in Bacterial Genomes

News

Scientists have now brought the family of LNM molecules even closer to clinical testing by “mining” the information stored in bacteria genomes. Their research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

READ MORE

Smartphone Case Offers Blood Glucose Monitoring on the Go

News

Engineers at the University of California San Diego have developed a smartphone case and app that could make it easier for patients to record and track their blood glucose readings, whether they’re at home or on the go.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE